aarjmd - Asian Academic Research

AARJMD
VOLUME 3
ISSUE 12
(DECEMBER 2016)
ISSN : 2319 - 2801
A Peer Reviewed International Journal of Asian
Academic Research Associates
AARJMD
ASIAN ACADEMIC RESEARCH
JOURNAL OF MULTIDISCIPLINARY
TOBACCO AND ALCOHOL CONSUMPTION ANTICIPATING THE PRESENCE
OF THE METABOLIC DISORDER
SIHEM. SOUISSI1; FETHI. BEN SLAMA2; ASMA. AYED3; HABIB. ASKRI4; NABIL.
GUERMAZI5; OMRANE. BEL HADJ6
1
University Tunis El Manor, Faculty of Science of Tunis, Laboratory of Biochemistry &
Techno biology.
2
National Institute of Public Health. Tunis. Tunisia
3
Expertise Centre for Aviation Medicine of Tunis. Tunisia
4
Expertise Centre for Aviation Medicine of Tunis. Tunisia
5
Expertise Centre for Aviation Medicine of Tunis. Tunisia
6
University Tunis El Manor, Faculty of Science of Tunis, Laboratory of Biochemistry &
Techno biology.
Abstract
Objective: To evaluate the effect of tobacco and alcohol consumption on the development of
obesity and metabolic syndrome (MS). Methods: The study was conducted on three groups
which are selected according to the criteria of the MS defined by the IDF and by the BMI.
P1: with MS only
P2: with MS and obesity
P3: obese only
Results: The three populations have a visceral obesity, with a significant difference. P2
consume a quantity of alcohol in percentage strictly exceeding 210 g/ week than P1 and P3,
(p=0.12). P1 consume in percentage of frequency of alcohol more than in P2 and P3, (p=0.3).
But the regular rate is more important for the P3 than the P1 or P2, (p=0.07). The difference
is not significant between the three populations in the number of packages of tobacco smoked
per year, even if P3 smoke in the number of packages of tobacco/ year less than P1 and P2.
Conclusion: The alcohol consumption appears to increase visceral obesity. The occasional
consumption with a very large amount at once and with a bad snacking is not fattening but
can lead to MS. But a regular consumption of alcohol, with a quantity less than 30 g/day, can
produce obesity without MS.
Key words: Obesity; Metabolic syndrome; tobacco; alcohol; healthy lifestyle.
Asian Academic Research Journal of Multidisciplinary
www.asianacademicresearch.org
AARJMD
VOLUME 3
ISSUE 12
(DECEMBER 2016)
ISSN : 2319 - 2801
References
1- Balkau, B., Deanfield, J., Després, J P., Bassand, J P., Fox, K K A., and Smith, S C.
(2007), ―International Day for the Evaluation of Abdominal Obesity (IDEA), A Study of
Waist Circumference, Cardiovascular Disease, and Diabetes Mellitus in 168 000 Primary
Care Patients in 63 Countries‖. Circulation, American Heart Association. 116 (17), pp.19421951.
2- OMS. (2000). Obésité : prévention et prise en charge de l'épidémie mondiale. Rapport
d’une Consultation de l’OMS 2000.Organisation mondiale de la Santé, Genève. pp 1-300.
3- Beck, E., Esser, N., Paquot, N., and Scheen, A J. (2009). Sujets de poids normal
«métaboliquement obèses» et sujets obèses «métaboliquement sains». Rev Med Suisse, pp.
1644-1649
4- Ruderman, N., Chisholm, D., Pi-Sunyer, X., and Schneider, S. (1998). The metabolically
obese, normal-weight individual revisited. Diabetes. 47, pp. 699-713.
5- Sims, E A. (2001). Are there persons who are obese, but metabolically healthy?
Metabolism. 50, pp. 1499-1504.
6- Esser, N., Paquot, N., Scheen, A J. (2009). Sujets «métaboliquement sains», bien
qu’obèses. 1re partie : Diagnostic, physiopathologie et prévalence. Obésité. 4, pp. 56-65.
7- Beck, N., Scheen, A J. (2009). Sujets «métaboliquement obèses » sans excès de poids : un
phénotype interpellant. Rev Med Liège. 64, pp14-22.
8- Beck, E., Paquot, N., and Scheen A J. (2008). Sujets «métaboliquement obèses» de poids
normal. 1re partie : Diagnostic, physiopathologie et prévalence. Obésité. 3, pp. 184-93.
9- Esser, N., Scheen, A J. (2009). Sujets obèses sans anomalies métaboliques. Rev Med
Liège. 64, pp.148-157.
10- Azizi, F., Salehi, P., Etemadi, A., and Zahedi A S. (2003). Prevalence of metabolic
syndrome in an urban population: Tehran Lipid and Glucose Study. Diabetes Res Clin Pract.
61, pp. 29-37.
11- Cameron, A J., Magliano, D J., Zimmet, P Z., Welborn, T., and Shaw, J E. (2007). The
metabolic syndrome in Australia: prevalence using four definitions. Diabetes Res. Clin. Pract.
77(3), pp. 471-478.
12- Balkau, B., Vernay, M., Mhamdi, L., Novak, M., Arondel, D., and Vol, S. (2003). The
incidence and persistence of the NCEP (National Cholesterol Education Program) metabolic
syndrome. The French D.E.S.I.R. study. Diabetes Metab. 29(5), pp. 526-532.
13- SFA. (2001). Recommandations pour la pratique clinique, Alcoologie et Addictologie. La
Société Française d'Alcoologie. 23 (Suppl 4), pp. 1S-76S.
14- Kiritze-Topor, P. (2008). Conduites d’alcoolisation: du risque à la dépendance- Repérage
et intervention brève en médecine générale. John libbey.Eurotext. 4(1), pp. 26-32.
15- Rehm , J., Monteiro, M. (2005). Alcohol consumption and burden of disease in the
Americas: implications for alcohol policy. Rev Panam Salud Publica. 18(4/5), pp. 241–8.
16- Shaper, A G., Ashby, D., and Pocock, S J. (1988). Blood pressure and hypertension in
middle-aged British men. J Hypertens. 6, pp. 367-374.
17- Amy, Z., Russell, F M., Dorn, J., Jo, L., Freudenheim., and Nochajski, T. (2006).
Lifetime Alcohol Drinking Pattern is Related to the Prevalence of Metabolic Syndrome. The
Asian Academic Research Journal of Multidisciplinary
www.asianacademicresearch.org
AARJMD
VOLUME 3
ISSUE 12
(DECEMBER 2016)
ISSN : 2319 - 2801
Western New York Health Study (WNYHS). European Journal of Epidemiology. 21(2), pp.
129-138.
18- Kenneth, J., Mukamal, M D., M P H, M A., and Rimm, E B. (2001). Alcohol’s Effects
on the Risk for Coronary Heart Disease. Harvard Medical School, Boston, Massachusett.
25(4), pp. 255-261.
19- Carreau J. Consommation d’alcool (Résumé), Musset S. Institut National de la Santé et
de la Recherche Médicale, France, pp. 1-13.
20- Rehm, J., Mathers, C., Popova, S., Thavorncharoensap, M., Teerawattananon, Y., Patra,
J. (2009). Global burden of disease and injury and economic cost attributable to alcohol use
and alcohol-use disorders. The Lancet. 373 (9682), pp. 2223–2233.
21- Anderson, P., Gual, A., Colom, J. (2005). Alcohol and Primary Health Care: Clinical
Guidelines on Identification and Brief Interventions. Department of Health of the
Government of Catalonia. Barcelona, pp. 1-172.
22- WHO (2004). Global Status Report on Alcohol. World Health Organization, Geneva, pp.
1-94.
23Casset, M. Addictions 5. Données
épidémiologiques, pp. 1-6.
http://www.lecomprime.com/cours/files/2013/09/Addictions-chap-5-epidemio.pdf (consulted
10/05/15).
24- SFA. Société Française d’Alcoologie. (2015). Mésusage de l’alcool, dépistage, diagnostic
et traitement (Recommandation de bonne pratique). Alcoologie et Addictologie. 37 (1), pp. 584.
25- Regula Thut Borner. (2007). L’alcool, une bombe calorique. LE MENU 6l2007, pp. 6869.
26- Breslow, R A., Chiung , C M,. Graubard, B I., Jacobovits, T., and Ashima K Kant
(2013). Diets of drinkers on drinking and nondrinking days: NHANES 2003–2008. Am J
Clin Nutr. 97 (5), pp. 1068-1075.
27- Wannamethee, S G., Shaper, A G. (2003). Alcohol, body weight, and weight gain in
middle-aged men. American Journal Clinical Nutrition. 77, pp.1312-1317.
28- Klatsky et al. (1996). Alcohol and hypertension. Clin Chim Acta. 246, pp. 91-105.
29- Taskinen, M R., Nikkilä, E A., Valimäki, M., Sanet, T., and Kuusit, T. (1987). Alcoholinduced changes in serum lipoproteins and in their metabolism. Am Heart J. 113, pp. 458264.
30- Toumbourow, JW., Williamas, I R., White, V M., Snow, P C., Munro, G D., and
Schofield, P E. (2004). Predition of alcohol-related harm from controlled drinking strategies
and
alcohol
consumption
trajectories.
Addiction.
99,
pp.
498-508.
31- U.S. Department of Health and Human Services . (2014). The Health consequences of
Asian Academic Research Journal of Multidisciplinary
www.asianacademicresearch.org
AARJMD
VOLUME 3
ISSUE 12
(DECEMBER 2016)
ISSN : 2319 - 2801
smoking—50 Years of Progress. A report of the surgeon général. Washington (DC), pp. 11081.
32- Smith, U. (1995). Smoking elicits the insulin resistance syndrome: new aspects of the
harmful effect of smoking. J Intern Med. 237, pp. 435-437.
33- Comité Française d’Education pour la Santé CFES (1999). La Santé en Chiffres
(Tabac), Education pour la santé pour mieux vivre, pp. 1-10.
34- Ben Romdhane H. (2007). Enquête Nationale Santé 2005-2006. Projet TAHINA- INSPAL, pp. 1-304.
35- Le Quotidien-Tunisie to day. (2014). Le tunisien dépense plus pour le tabac que pour sa
santé. Actualités de la Tunisie. http://www.tunisia-today.com/archives/11823 (consulted
04/11/14)
36- Weitzman, M., Cook, S., Auinger, P., Florin, T A., Daniels,S., Nguyen, M., Winickoff,
J P. (2005). Tobacco Smoke Exposure Is Associated With the Metabolic Syndrome in
Adolescents. American Heart Association. Circulation.112, pp. 862-869.
37- Bjartveit, K.., Tverdal, A. (2005). Health consequences of smoking 1-4 cigarettes per
day. Tobacco Control. Vol. 14 (5), pp. 315-320.
38- Peto R (1986). Influence of dose and duration of smoking on lung cancer rates. IARC
Sci Publ; (74):23-33.
39- Mahmud A, Feely J. (2003). Effect of smoking on arterial stiffness and pulse pressure
amplification. Hypertension. 41(1), pp. 183-187.
40- Inpes. (2015). Les risques du tabagisme et les bénéfices de l’arrêt/ Les solutions pour
arrêter de fumer. Dépliant Inpes, réf. 220-17012-de « J’arrête de fumer, des méthodes pour y
parvenir ». Guide pratique Inpes, réf. 220-90411-B, France, pp. 1-2.
Asian Academic Research Journal of Multidisciplinary
www.asianacademicresearch.org